Pediatrics

The Biology and Genetics of AHC: Understanding the 'Pump'

At a Glance

Alternating Hemiplegia of Childhood (AHC) is primarily caused by mutations in the ATP1A3 gene, which regulates the brain's electrical signals. Specific mutations, like E815K or D801N, help predict symptom severity. Whole Exome Sequencing (WES) is the most effective diagnostic test.

To understand Alternating Hemiplegia of Childhood (AHC), it helps to think of the brain as a complex electrical grid. For this grid to function, every nerve cell (neuron) needs to maintain a specific electrical charge. This charge is managed by a biological “battery charger” called the sodium-potassium pump (or Na+/K±ATPase) ^[1]^[2].

The Role of the ATP1A3 Gene

The ATP1A3 gene provides the instructions for building a critical part of this pump ^[3]. In a healthy brain, the pump constantly moves sodium out of the cell and pulls potassium in, keeping the cell ready to fire a signal.

When a mutation occurs in the ATP1A3 gene, the pump becomes less efficient or stops working entirely ^[4]. This causes neurons to become “hyperexcitable”—they fire signals too easily and struggle to reset themselves ^[5]^[6]. This electrical instability is what leads to the sudden “spells” of paralysis and muscle twisting that define AHC.

How Your Child’s Mutation Influences Their Path

Not all AHC mutations are the same. Scientists have identified “hotspot” mutations that help doctors predict a child’s likely symptoms and challenges ^[7].

E815K (The “Severe” Variant): This mutation is often linked to the most significant challenges. Children with E815K typically experience symptoms earlier in life and may face more severe developmental delays, a higher risk of seizures, and greater difficulty learning to walk ^[7]^[8].
D801N (The Most Common Variant): This is the most frequently seen mutation in AHC. It generally falls in the middle of the severity spectrum ^[5]. However, it is specifically noted for a higher association with certain cardiac rhythm risks, requiring regular heart monitoring (EKGs) ^[9]. For more on this risk, refer to The Long Road Ahead: Building Your Child’s Care Team.
G947R (The “Milder” Variant): While still a serious condition, children with the G947R mutation often have better motor and cognitive outcomes compared to those with E815K ^[10]^[11].

When the ATP1A3 Test is Negative

About 15% of children with AHC symptoms do not have a mutation in the ATP1A3 gene ^[12]. In these cases, other genes may be the cause. These “AHC-like” conditions are important to identify because they may have different treatment paths:

SCN2A or ATP1A2: These genes also manage the brain’s electrical balance and can cause similar alternating weakness ^[13]^[14].
RHOBTB2: This can mimic AHC but is often associated with a smaller head size (microcephaly) and more severe seizures ^[15].
ADCY5: This gene typically causes more constant movement disorders rather than the “on-off” paralysis of AHC ^[16].

The Gold Standard: Whole Exome Sequencing (WES)

Finding the exact genetic cause is essential for tailoring your child’s care. Doctors may initially start with a fast, targeted gene panel. However, if this is negative—or increasingly, as a first-line test—doctors recommend Whole Exome Sequencing (WES) ^[17]. Unlike a standard test that looks at one gene, WES scans all ~20,000 genes in the human body simultaneously ^[18]. WES is incredibly effective at ending the “diagnostic odyssey,” providing answers for up to 50% of children with unexplained neurological disorders, and definitively catching AHC or its mimics ^[19]^[20].

Common questions in this guide

What gene causes Alternating Hemiplegia of Childhood (AHC)?

In about 85% of cases, AHC is caused by a mutation in the ATP1A3 gene. This gene is responsible for building the sodium-potassium pump, which is critical for regulating electrical signals in the brain's nerve cells.

What does the D801N mutation mean for my child?

The D801N mutation is the most frequent genetic variant in AHC and generally causes moderate symptoms. However, children with this specific mutation have a higher risk of heart rhythm issues and require regular cardiac monitoring with EKGs.

What happens if my child tests negative for the ATP1A3 gene?

About 15% of children with AHC symptoms do not have an ATP1A3 mutation. In these cases, doctors will look for mutations in other genes, such as SCN2A, ATP1A2, ADCY5, or RHOBTB2, which can cause similar neurological symptoms.

Why do doctors recommend Whole Exome Sequencing (WES) for AHC?

Unlike targeted gene panels that only check specific genes, Whole Exome Sequencing scans all 20,000 genes in the human body simultaneously. This comprehensive approach is highly effective at pinpointing the exact genetic cause of AHC or identifying mimicking conditions.

Are all AHC mutations equally severe?

No, the severity of AHC often depends on the specific mutation variant. For example, the E815K variant is typically linked to earlier onset and more severe developmental delays, while the G947R variant is often associated with better motor and cognitive outcomes.

Curated prompts to bring to your next appointment.

1.What is the exact genetic change found in my child (e.g., E815K, D801N, or G947R), and what does the current literature say about this specific variant?
2.If my child tested negative for ATP1A3, were genes like RHOBTB2, SCN2A, or ADCY5 included in the screening?
3.Was Whole Exome Sequencing (WES) performed, or was it a smaller, targeted gene panel?
4.Based on my child's specific mutation, should we be particularly vigilant about certain risks, like epilepsy or heart rhythm issues?
5.How often should we repeat genetic counseling as new research on ATP1A3 variants emerges?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (20)

1
Alternating Hemiplegia of Childhood: Understanding the Genotype-Phenotype Relationship of ATP1A3 Variations.
Capuano A, Garone G, Tiralongo G, Graziola F
The application of clinical genetics 2020; (13()):71-81 doi:10.2147/TACG.S210325.
PMID: 32280259
2
Na+/K+-ATPase: a multifunctional target in type 2 diabetes and pancreatic islets.
Mou L, Fu Z, Wang TB, et al.
Frontiers in immunology 2025; (16()):1555310 doi:10.3389/fimmu.2025.1555310.
PMID: 40046060
3
ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids.
You Y, Zhang Z, Sultana N, et al.
Science advances 2023; (9(37)):eadi3647 doi:10.1126/sciadv.adi3647.
PMID: 37713494
4
Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis.
Muthaffar OY, Alqarni A, Shafei JA, et al.
Genes & genomics 2024; (46(4)):475-487 doi:10.1007/s13258-023-01481-8.
PMID: 38243045
5
Alternating hemiplegia of childhood: evolution over time and mouse model corroboration.
Uchitel J, Wallace K, Tran L, et al.
Brain communications 2021; (3(3)):fcab128 doi:10.1093/braincomms/fcab128.
PMID: 34396101
6
Mechanisms of increased hippocampal excitability in the Mashl+/- mouse model of Na+ /K+ -ATPase dysfunction.
Hunanyan AS, Helseth AR, Abdelnour E, et al.
Epilepsia 2018; (59(7)):1455-1468 doi:10.1111/epi.14441.
PMID: 29889309
7
[Genotype-phenotype correlation in patients with alternating hemiplegia of childhood].
Li SP, Zhang YH, Yang XL, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2018; (56(11)):811-817 doi:10.3760/cma.j.issn.0578-1310.2018.11.004.
PMID: 30392204
8
Alternating Hemiplegia of Childhood: Genotype-Phenotype Correlations in a Cohort of 39 Italian Patients.
Cordani R, Stagnaro M, Pisciotta L, et al.
Frontiers in neurology 2021; (12()):658451 doi:10.3389/fneur.2021.658451.
PMID: 33897609
9
ATP1A3-Encoded Sodium-Potassium ATPase Subunit Alpha 3 D801N Variant Is Associated With Shortened QT Interval and Predisposition to Ventricular Fibrillation Preceded by Bradycardia.
Moya-Mendez ME, Ogbonna C, Ezekian JE, et al.
Journal of the American Heart Association 2021; (10(17)):e019887 doi:10.1161/JAHA.120.019887.
PMID: 34459253
10
Clinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood-a study of 155 patients.
Panagiotakaki E, De Grandis E, Stagnaro M, et al.
Orphanet journal of rare diseases 2015; (10()):123 doi:10.1186/s13023-015-0335-5.
PMID: 26410222
11
Navigating the Complexity of Alternating Hemiplegia in Childhood: A Comprehensive Review.
Rissardo JP, Vora NM, Singh Y, et al.
Rambam Maimonides medical journal 2024; (15(3)) doi:10.5041/RMMJ.10529.
PMID: 39088707
12
An Inherited Cause of Stroke Mimic in a Toddler.
Yoganathan S, Kumar M, Sushma L, et al.
Indian journal of pediatrics 2022; (89(1)):98 doi:10.1007/s12098-021-03904-4.
PMID: 34468936
13
Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene.
Panagiotakaki E, Tiziano FD, Mikati MA, et al.
European journal of human genetics : EJHG 2024; (32(2)):224-231 doi:10.1038/s41431-023-01489-4.
PMID: 38097767
14
A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients.
Calame DG, Houck K, Lotze T, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2021; (31()):21-26 doi:10.1016/j.ejpn.2021.01.004.
PMID: 33578253
15
RHOBTB2 p.Arg511Trp Mutation in Early Infantile Epileptic Encephalopathy-64: Review and Case Report.
Fonseca J, Melo C, Ferreira C, et al.
Journal of pediatric genetics 2023; (12(2)):155-158 doi:10.1055/s-0040-1722288.
PMID: 37090824
16
Generation of an induced pluripotent stem cell line (UCLi026-A) from a patient with ADCY5-related disease carrying the heterozygous variant c.1253G > A; (p. Arg418Gln).
Alhaque S, Budinger D, Garavaglia B, et al.
Stem cell research 2025; (84()):103669 doi:10.1016/j.scr.2025.103669.
PMID: 39919432
17
Expanding Phenotype of ATP1A3 - Related Disorders: A Case Series.
De Vrieze J, van de Laar IMBH, de Rijk-van Andel JF, et al.
Child neurology open 2021; (8()):2329048X211048068 doi:10.1177/2329048X211048068.
PMID: 34761051
18
Trio-whole exome sequencing reveals the importance of de novo variants in children with intellectual disability and developmental delay.
Li C, Wang Y, Zeng C, et al.
Scientific reports 2024; (14(1)):27590 doi:10.1038/s41598-024-79431-x.
PMID: 39528574
19
Exome sequencing improves the molecular diagnostics of paediatric unexplained neurodevelopmental disorders.
Wayhelova M, Vallova V, Broz P, et al.
Orphanet journal of rare diseases 2024; (19(1)):41 doi:10.1186/s13023-024-03056-6.
PMID: 38321498
20
Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.
Wright CF, McRae JF, Clayton S, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(10)):1216-1223 doi:10.1038/gim.2017.246.
PMID: 29323667

This page provides educational information about AHC genetics and ATP1A3 mutations. Always consult a pediatric neurologist or geneticist to interpret your child's specific genetic test results.

Get notified when new evidence is published on Alternating hemiplegia of childhood.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents